Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Natera, Inc. | Director | Common Stock | 998 | $65.6K | $65.70 | Jul 8, 2022 | Direct |
LEAP THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 55K | Jan 31, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NTRA | Natera, Inc. | Jul 8, 2022 | 1 | $0 | 4/A | Sep 2, 2022 | Director |
NTRA | Natera, Inc. | May 27, 2022 | 1 | $0 | 4 | Jun 1, 2022 | Director |
LPTX | LEAP THERAPEUTICS, INC. | Jan 31, 2022 | 1 | $0 | 4 | Feb 2, 2022 | Director |
NTRA | Natera, Inc. | Nov 17, 2021 | 2 | $0 | 4 | Nov 19, 2021 | Director |
LPTX | LEAP THERAPEUTICS, INC. | Sep 8, 2021 | 2 | $0 | 4 | Sep 10, 2021 | Director |
NTRA | Natera, Inc. | May 28, 2021 | 2 | $0 | 4 | Jun 2, 2021 | Director |